Wednesday, March 27, 2013
(HealthDay News) — There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report appearing in the journal Cancer Epidemiology, Biomarkers & Prevention.
“Cancer is often not the immediately fatal diagnosis it often was in the past,” said one expert, Dr. William Oh, chief of the division of hematology/oncology at Mount Sinai Medical Center in New York City. He was not involved in the new report, which comes from the American Association for Cancer Research (AACR).
As the American population gets older, more cancer survivors can be expected, added Julia Rowland, director of the Office of Cancer Survivorship at the U.S. National Cancer Institute. “By 2020, we expect that two-thirds of cancer survivors are going to be aged 65 or older,” she said in an AACR news release.
The report, based on an analysis of national data, also found that patients with certain types of cancers account for a large proportion of the survivors. For example, breast cancer patients account for 22 percent of survivors, while prostate cancer survivors account for 20 percent.
People with lung cancer, the second most commonly diagnosed cancer, account for only 3 percent of survivors, according to the report.
“For patients with prostate cancer, we have a nearly 100 percent five-year survival rate, and breast cancer has made tremendous strides as well, with five-year survival rising from 75 percent in 1975 to almost 89 percent in 2012,” Rowland said. “However, we clearly need to have better diagnostic tools and better treatments for lung cancer.”
She said the rising number of cancer survivors will present challenges for the health care system.
“How to ensure that these patients lead not only long lives, but healthy and productive lives, will be a vital challenge to all of us,” Rowland said.
Oh agreed. “This important paper highlights an observation most oncologists have made over the past several years — namely that with earlier diagnosis and better treatments, the numbers of cancer survivors is rapidly increasing,” he said. “The urgent need though is for us to better understand how to care for cancer survivors. As cancer becomes a ‘chronic disease,’ we need more research to optimally manage the patients who survive cancer.”
SOURCES: William Oh, M.D., chief, division of hematology/oncology, Mount Sinai Medical Center, New York City; American Association for Cancer Research, news release, March 27, 2013
November 23, 2013
Since its founding in 1997, Golfers Against Cancer has had one goal: to fund cancer research. Virtually all the money raised in GAC tournaments and events goes directly to cancer research organizations, including the CHRISTUS Stehlin Foundation.
August 2, 2013
The 14th Annual Luci Bonneau Memorial Striking Against Breast Cancer Mixed Doubles Bowling Tournament is one of the most prestigious doubles events in America. The tournament includes a Pro-Am - your chance to bowl with the pros to cure breast cancer!
October 19, 2013 | 7:00 p.m.
Get ready to disco and dance the night away at The Friends of CHRISTUS Stehlin Gala! Premiering “STAYIN’ ALIVE,” The Greatest Bee Gees Tribute Band with Members of the Houston Symphony Orchestra and America’s first Mash Up Group, “THE COMPANY MEN.”
May 4, 2013
On May 4th, 2013, young women will take the field for the first time in an exciting powder puff football game with teams comprised of some of best and brightest in Austin. The game is designed to bring the passion and spirit of young community leaders together to support Young Texans Against Cancer.
“Compared with other anticancer drugs at similar stages of development, camptothecins have demonstrated a much higher anticancer activity. Camptothecins can be envisioned as the ultimate anticancer drug when fully developed.”
National Academy of Science, 1995
CHRISTUS Stehlin Foundation for Cancer Research will join CHRISTUS St. Catherine and CHRISTUS St. John in a new partnership with Houston Methodist.
There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report. >> Click article title for more.